Companies: 10,795·Total market cap: $144.5T
Panacea Life Sciences Holdings, Inc.

Panacea Life Sciences Holdings, Inc.

PLSHOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$679161
P/E Ratio—
52W High$0.1996
52W Low$0.0211
Cash on HandFinancialsRevenue

Panacea Life Sciences Holdings, Inc. (PLSH) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

PLSH · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$41,426▼ -97.2% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$41,426
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-97.2%
vs prior fiscal year
Latest Quarter
$91,164
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$41,426Cash on Hand
Total Debt$214,753Total Debt
Net Cash / Net Debt−$173,327Net Debt Position
Cash vs Debt Ratio
Cash 16%Debt 84%

Panacea Life Sciences Holdings, Inc. carries a net debt position of $173,327. Total debt ($214,753) exceeds cash on hand ($41,426). Panacea Life Sciences Holdings, Inc. cash vs debt ratio: 16% cash / 84% debt.

Net Cash = Cash & ST Investments − Total Debt$41,426 − $214,753 = −$173,327

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
PLSH annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$0.0M-97.2%
Dec 31, 2024$1.5M+1168.3%
Dec 31, 2023$0.1M-89.6%
Dec 31, 2022$1.1M-70.8%
Dec 31, 2021$3.8M+29.7%
PLSH cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc.YOU
PLSH
$0.0M6.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Panacea Life Sciences Holdings, Inc. (PLSH) cash on hand as of December 31, 2025 is $41,426, comprising $41,426 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Panacea Life Sciences Holdings, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Panacea Life Sciences Holdings, Inc. cash reserves or cash position.

Panacea Life Sciences Holdings, Inc. annual cash on hand history shows decreased -97.2% in 2025: decreased -97.2% in 2025. Panacea Life Sciences Holdings, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Panacea Life Sciences Holdings, Inc. carries total debt of $214,753 against cash of $41,426, resulting in a net debt position of -$173,327. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

PLSH cash on hand · 5 questions

As of December 31, 2025, Panacea Life Sciences Holdings, Inc. (PLSH) has $41,426 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $41,426 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $91,164. Data sourced from the annual 10-K filing via FMP.

PLSH cash on handPLSH cash reservesPLSH cash 2025how much cash does PLSH have

▸ Source: FMP /balance-sheet-statement · US GAAP · Panacea Life Sciences Holdings, Inc. · Panacea Life Sciences Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025